Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile.

The article presents a study on the effectiveness and safety of fecal transplant in the treatment of immunocompromised as non-immunocompromised patients for Clostridium difficile infection (CDI). Topics covered include the findings of the study which show that most (IBD) patients seem to tolerate (FMT) and could be cured of their CDI with FMT.